DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting the publication of a new study in “Frontiers in Physiology,” a peer-reviewed journal; the study shows the effectiveness DRIO’s musculoskeletal solution, which uses real-time biofeedback and behavior training to reduce back pain. According to the announcement, the study evaluated retrospective data from 981 individuals who used Dario Move’s posture trainer for at least eight weeks, focusing on the relationship between the amount of time spent training, the use of the device and reduction in back-pain levels. Results indicated that, on average, users reported a 50% reduction in pain, with 60% of users reporting clinically important pain reduction after four weeks of biofeedback training; that number increased to 76% of users showing some pain reduction after eight weeks. Dario’s Move posture training solution involves a wearable biofeedback device and real-time data feedback. The device is designed to vibrate when the user slouches, which develops awareness and encourages proper posture. “Addressing chronic pain with posture training is known to have a positive impact on pain, and now we are able to better define that relationship and the role of the device,” said Dario vice president of clinical and scientific affairs Yifat Hershcovitz, PhD. “We are thrilled to demonstrate our ability to use real-time data from the sensor to drive healthier musculoskeletal health behaviors through ongoing training is now positively linked clinical outcomes.”
To view the full press release, visit https://ibn.fm/UzHlA
About DarioHealth Corp.
DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork